Quick Answer
Beta Bionics, Inc. reported Total Revenue of $100.25 million for fiscal year 2025.
Beta Bionics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $100.25M | +53.9% |
| 2024 | $65.12M | +442.9% |
| 2023 | $11.99M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $27.25M | +63.1% | +17.3% |
| June 30, 2025 | $23.24M | +54.4% | +31.7% |
| March 31, 2025 | $17.64M | +36.4% | +5.6% |
| September 30, 2024 | $16.70M | — | +11.0% |
| June 30, 2024 | $15.05M | — | +16.3% |
| March 31, 2024 | $12.93M | — | — |
- Beta Bionics, Inc. showed an increase of +53.9% in Total Revenue compared to the prior fiscal year.
- Over the 2023–2025 period, Beta Bionics, Inc.’s total revenue has grown by 735.8% (from $11.99 million to $100.25 million).
- The most recent figure is from Beta Bionics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: